Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Daniel E. Di Zeo-Sánchez, Antonio Segovia-Zafra, Gonzalo Matilla-Cabello, José M. Pinazo-Bandera, Raúl J. Andrade, M. Isabel Lucena & Marina Villanueva-Paz. (2022) Modeling drug-induced liver injury: current status and future prospects. Expert Opinion on Drug Metabolism & Toxicology 18:9, pages 555-573.
Read now
Read now
Julia Pletz, Steven J. Enoch, Diviya M. Jais, Claire L. Mellor, Gopal Pawar, James W. Firman, Judith C. Madden, Steven D. Webb, Carlos A. Tagliati & Mark T. D. Cronin. (2018) A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist prediction. Expert Opinion on Drug Metabolism & Toxicology 14:12, pages 1225-1253.
Read now
Read now
Pan Zhao, Bin Liu & Chunya Wang. (2017) Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model. Clinical Toxicology 55:9, pages 996-1000.
Read now
Read now
Isoude A. Kuijper, Huan Yang, Bob Van De Water & Joost B. Beltman. (2017) Unraveling cellular pathways contributing to drug-induced liver injury by dynamical modeling. Expert Opinion on Drug Metabolism & Toxicology 13:1, pages 5-17.
Read now
Read now
X.-W. Zhu, Y.-J. Xin & Q.-H. Chen. (2016) Chemical and in vitro biological information to predict mouse liver toxicity using recursive random forests. SAR and QSAR in Environmental Research 27:7, pages 559-572.
Read now
Read now
Qiuping Guo, Wei Yang, Baiquan Xiao, Hong Zhang, Xialing Lei, Huiyu Ou, Renan Qin & Ruomin Jin. (2015) Study on early biomarkers of zebrafish liver injury induced by acetaminophen. Toxin Reviews 34:1, pages 28-36.
Read now
Read now
M. Hewitt, S. J. Enoch, J. C. Madden, K. R. Przybylak & M. T. D. Cronin. (2013) Hepatotoxicity: A scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action. Critical Reviews in Toxicology 43:7, pages 537-558.
Read now
Read now
Maiyen Tran Hawkins & James H Lewis. (2012) Latest advances in predicting DILI in human subjects: focus on biomarkers. Expert Opinion on Drug Metabolism & Toxicology 8:12, pages 1521-1530.
Read now
Read now
Articles from other publishers (61)
Pawan Prabhakar, Sayan Mukherjee, Ankit Kumar, Suraj Kumar, Deepak Kumar Verma, Santanu Dhara, Mrinal Kumar Maiti & Mamoni Banerjee. (2023) Optimization of microwave-assisted extraction (MAE) of key phenolic compounds from pigeon pea (Cajanus cajan L.), their characterization, and measurement of their anti-diabetic and cytotoxic potential. Journal of Food Measurement and Characterization 17:6, pages 5697-5720.
Crossref
Crossref
Sebastian Martinez-Lopez, Enrique Angel-Gomis, Elisabet Sanchez-Ardid, Alberto Pastor-Campos, Joanna Picó & Isabel Gomez-Hurtado. (2023) The 3Rs in Experimental Liver Disease. Animals 13:14, pages 2357.
Crossref
Crossref
Jiaying Lin, Min Li, Wenyao Mak, Yufei Shi, Xiao Zhu, Zhijia Tang, Qingfeng He & Xiaoqiang Xiang. (2022) Applications of In Silico Models to Predict Drug-Induced Liver Injury. Toxics 10:12, pages 788.
Crossref
Crossref
Mirushan Arunasalam, Vivian Chong, Sharanya Ranee Mareshvaran, Venessa Ngui Fern Yee, Anand Gaurav, Shamala Salvamani, Crystale Siew Ying Lim & Baskaran Gunasekaran. (2022) Identification of natural product inhibitors of de novo lipogenesis enzymes as an anti-cancer strategy: An in silico approach. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 1-14.
Crossref
Crossref
Jingyu Lee, Myeong-Sang Yu & Dokyun Na. (2022) DILI-Stk: An Ensemble Model for the Prediction of Drug-induced Liver
Injury of Drug Candidates. Current Bioinformatics 17:3, pages 296-303.
Crossref
Crossref
Claire Ellison, Mark Hewitt & Katarzyna Przybylak. 2022. In Silico Methods for Predicting Drug Toxicity. In Silico Methods for Predicting Drug Toxicity
355
392
.
Yukun Wang & Xuebo Chen. (2021) Joint Decision-Making Model Based on Consensus Modeling Technology for the Prediction of Drug-Induced Liver Injury. Journal of Chemistry 2021, pages 1-20.
Crossref
Crossref
Antonio Segovia-Zafra, Daniel E. Di Zeo-Sánchez, Carlos López-Gómez, Zeus Pérez-Valdés, Eduardo García-Fuentes, Raúl J. Andrade, M. Isabel Lucena & Marina Villanueva-Paz. (2021) Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction. Acta Pharmaceutica Sinica B 11:12, pages 3685-3726.
Crossref
Crossref
Arianna Bassan, Vinicius M. Alves, Alexander Amberg, Lennart T. Anger, Scott Auerbach, Lisa Beilke, Andreas Bender, Mark T.D. Cronin, Kevin P. Cross, Jui-Hua Hsieh, Nigel Greene, Raymond Kemper, Marlene T. Kim, Moiz Mumtaz, Tobias Noeske, Manuela Pavan, Julia Pletz, Daniel P. Russo, Yogesh Sabnis, Markus Schaefer, David T. Szabo, Jean-Pierre Valentin, Joerg Wichard, Dominic Williams, David Woolley, Craig Zwickl & Glenn J. Myatt. (2021) In silico approaches in organ toxicity hazard assessment: Current status and future needs in predicting liver toxicity. Computational Toxicology 20, pages 100187.
Crossref
Crossref
Keerthana Jaganathan, Hilal Tayara & Kil To Chong. (2021) Prediction of Drug-Induced Liver Toxicity Using SVM and Optimal Descriptor Sets. International Journal of Molecular Sciences 22:15, pages 8073.
Crossref
Crossref
Heather P Llewellyn, Vishal S Vaidya, Zhenyu Wang, Qinghai Peng, Craig Hyde, David Potter, Jianying Wang, Qing Zong, Seda Arat, Matt Martin, Katherine Masek-Hammerman, Roscoe Warner, Kent Johnson, Gerd A Kullak-Ublick, Guruprasad P Aithal, James W Dear & Shashi K Ramaiah. (2021) Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans. Toxicological Sciences 181:1, pages 23-34.
Crossref
Crossref
Andreu Vall, Yogesh Sabnis, Jiye Shi, Reiner Class, Sepp Hochreiter & Günter Klambauer. (2021) The Promise of AI for DILI Prediction. Frontiers in Artificial Intelligence 4.
Crossref
Crossref
James W. Firman, Cynthia B. Pestana, James F. Rathman, Mathieu Vinken, Chihae Yang & Mark T. D. Cronin. (2020)
A Robust, Mechanistically Based
In Silico
Structural Profiler for Hepatic Cholestasis
. Chemical Research in Toxicology 34:2, pages 641-655.
Crossref
Crossref
Kaori Ambe, Kazuyuki Ohya, Waki Takada, Masaharu Suzuki & Masahiro Tohkin. (2021)
In Silico
Approach to Predict Severe Cutaneous Adverse Reactions Using the Japanese Adverse Drug Event Report Database
. Clinical and Translational Science.
Crossref
Crossref
Olivier J.M. Béquignon, Gopal Pawar, Bob van de Water, Mark T.D. Cronin & Gerard J.P. van Westen. 2021. Systems Medicine. Systems Medicine
308
329
.
Saravanakumar Selvaraj, Jung-Hwa Oh & Jürgen Borlak. (2020) An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac. Archives of Toxicology 94:8, pages 2733-2748.
Crossref
Crossref
Judith C. Madden, Steven J. Enoch, Alicia Paini & Mark T.D. Cronin. (2020)
A Review of
In Silico
Tools as Alternatives to Animal Testing: Principles, Resources and Applications
. Alternatives to Laboratory Animals 48:4, pages 146-172.
Crossref
Crossref
Ik Sup Jin, Moon Sup Yoon, Chun-Woong Park, Jin Tae Hong, Youn Bok Chung, Jin-Seok Kim & Dae Hwan Shin. (2020) Replacement techniques to reduce animal experiments in drug and nanoparticle development. Journal of Pharmaceutical Investigation 50:3, pages 327-335.
Crossref
Crossref
Benjamin Bajželj & Viktor Drgan. (2020) Hepatotoxicity Modeling Using Counter-Propagation Artificial Neural Networks: Handling an Imbalanced Classification Problem. Molecules 25:3, pages 481.
Crossref
Crossref
Jae H. Chang, Dewakar Sangaraju, Ning Liu, Allan Jaochico & Emile Plise. (2019) Comprehensive Evaluation of Bile Acid Homeostasis in Human Hepatocyte Co-Culture in the Presence of Troglitazone, Pioglitazone, and Acetylsalicylic Acid. Molecular Pharmaceutics 16:10, pages 4230-4240.
Crossref
Crossref
Wang, Xiao, Chen & Wang. (2019) In Silico Prediction of Drug-Induced Liver Injury Based on Ensemble Classifier Method. International Journal of Molecular Sciences 20:17, pages 4106.
Crossref
Crossref
Eva Gijbels, Vânia Vilas-Boas, Neel Deferm, Lindsey Devisscher, Hartmut Jaeschke, Pieter Annaert & Mathieu Vinken. (2019) Mechanisms and in vitro models of drug-induced cholestasis. Archives of Toxicology 93:5, pages 1169-1186.
Crossref
Crossref
Shuaibing He, Tianyuan Ye, Ruiying Wang, Chenyang Zhang, Xuelian Zhang, Guibo Sun & Xiaobo Sun. (2019) An In Silico Model for Predicting Drug-Induced Hepatotoxicity. International Journal of Molecular Sciences 20:8, pages 1897.
Crossref
Crossref
Xiaoyong Li, Jiaqiong Lin, Yan Lin, Zena Huang, Yuguo Pan, Peng Cui, Chicai Yu, Cun Cai & Jintang Xia. (2018) Hydrogen sulfide protects against acetaminophen‐induced acute liver injury by inhibiting apoptosis via the JNK/MAPK signaling pathway. Journal of Cellular Biochemistry 120:3, pages 4385-4397.
Crossref
Crossref
Lu Liu, Li Fu, Jin-Wei Zhang, Hui Wei, Wen-Ling Ye, Zhen-Ke Deng, Lin Zhang, Yan Cheng, Defang Ouyang, Qian Cao & Dong-Sheng Cao. (2018) Three-Level Hepatotoxicity Prediction System Based on Adverse Hepatic Effects. Molecular Pharmaceutics 16:1, pages 393-408.
Crossref
Crossref
Minjun Chen, Jieqiang Zhu, Kristin Ashby, Leihong Wu, Zhichao Liu, Ping Gong, Chaoyang Zhang, Jürgen Borlak, Huixiao Hong & Weida Tong. 2019. Advances in Computational Toxicology. Advances in Computational Toxicology
259
278
.
Haixin Ai, Wen Chen, Li Zhang, Liangchao Huang, Zimo Yin, Huan Hu, Qi Zhao, Jian Zhao & Hongsheng Liu. (2018) Predicting Drug-Induced Liver Injury Using Ensemble Learning Methods and Molecular Fingerprints. Toxicological Sciences 165:1, pages 100-107.
Crossref
Crossref
Xiao Li, Yaojie Chen, Xinrui Song, Yuan Zhang, Huanhuan Li & Yong Zhao. (2018)
The development and application of
in silico
models for drug induced liver injury
. RSC Advances 8:15, pages 8101-8111.
Crossref
Crossref
Franck A. Atienzar & Jean-Marie Nicolas. 2018. Drug-Induced Liver Toxicity. Drug-Induced Liver Toxicity
125
150
.
Huixiao Hong, Shraddha Thakkar, Minjun Chen & Weida Tong. (2017) Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs. Scientific Reports 7:1.
Crossref
Crossref
Bruno Stieger & Zainab M. Mahdi. (2017) Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease. Journal of Pharmaceutical Sciences 106:9, pages 2295-2301.
Crossref
Crossref
Xiang-Wei Zhu & Shao-Jing Li. (2017) In Silico Prediction of Drug-Induced Liver Injury Based on Adverse Drug Reaction Reports. Toxicological Sciences 158:2, pages 391-400.
Crossref
Crossref
Mark T.D. Cronin, Steven J. Enoch, Claire L. Mellor, Katarzyna R. Przybylak, Andrea-Nicole Richarz & Judith C. Madden. (2017)
In Silico
Prediction of Organ Level Toxicity: Linking Chemistry to Adverse Effects
. Toxicological Research 33:3, pages 173-182.
Crossref
Crossref
Sergey Ivanov, Maxim Semin, Alexey Lagunin, Dmitry Filimonov & Vladimir Poroikov. (2017)
In Silico
Identification of Proteins Associated with Drug-induced Liver Injury Based on the Prediction of Drug-target Interactions
. Molecular Informatics 36:7, pages 1600142.
Crossref
Crossref
Peter Bloomingdale, Conrad Housand, Joshua F. Apgar, Bjorn L. Millard, Donald E. Mager, John M. Burke & Dhaval K. Shah. (2017) Quantitative systems toxicology. Current Opinion in Toxicology 4, pages 79-87.
Crossref
Crossref
A.K. Daly. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
204
216
.
A. Brigo & W. Muster. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
233
258
.
Kevin A. Ford. (2017) Refinement, Reduction, and Replacement of Animal Toxicity Tests by Computational Methods. ILAR Journal 57:2, pages 226-233.
Crossref
Crossref
Frank D. Sistare, William B. Mattes & Edward L. LeCluyse. (2017) The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development. ILAR Journal 57:2, pages 186-211.
Crossref
Crossref
Fabiola Pizzo, Anna Lombardo, Alberto Manganaro & Emilio Benfenati. (2016) A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts. Frontiers in Pharmacology 7.
Crossref
Crossref
Grace Patlewicz & Jeremy M. Fitzpatrick. (2016)
Current and Future Perspectives on the Development, Evaluation, and Application of
in Silico
Approaches for Predicting Toxicity
. Chemical Research in Toxicology 29:4, pages 438-451.
Crossref
Crossref
J. Gerry Kenna, Mikael Persson, Scott Q. Siler, Ke Yu, Chuchu Hu, Minjun Chen, Joshua Xu, Weida Tong, Yvonne Will & Michael D. Aleo. 2016. Drug Discovery Toxicology. Drug Discovery Toxicology
93
129
.
Chen Zhang, Feixiong Cheng, Weihua Li, Guixia Liu, Philip W Lee & Yun Tang. (2016)
In silico
Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method
. Molecular Informatics 35:3-4, pages 136-144.
Crossref
Crossref
Mark Avigan, Robert Mozersky & Leonard Seeff. (2016) Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. International Journal of Molecular Sciences 17:3, pages 331.
Crossref
Crossref
Mark Hewitt & Katarzyna Przybylak. 2016. In Silico Methods for Predicting Drug Toxicity. In Silico Methods for Predicting Drug Toxicity
201
236
.
James H. Lewis. (2015) The Art and Science of Diagnosing and Managing Drug-induced Liver Injury in 2015 and Beyond. Clinical Gastroenterology and Hepatology 13:12, pages 2173-2189.e8.
Crossref
Crossref
Mathieu Vinken. (2015) Adverse Outcome Pathways and Drug-Induced Liver Injury Testing. Chemical Research in Toxicology 28:7, pages 1391-1397.
Crossref
Crossref
Emanuel Raschi. (2015) Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World Journal of Hepatology 7:13, pages 1761.
Crossref
Crossref
James H. Lewis. (2014) Drug-Induced Liver Injury, Dosage, and Drug Disposition: Is Idiosyncrasy Really Unpredictable?. Clinical Gastroenterology and Hepatology 12:9, pages 1556-1561.
Crossref
Crossref
Xiang-Wei Zhu, Alexander Sedykh & Shu-Shen Liu. (2014)
Hybrid
in silico
models for drug-induced liver injury using chemical descriptors and
in vitro
cell-imaging information
. Journal of Applied Toxicology 34:3, pages 281-288.
Crossref
Crossref
Dennie GA HebelsMarlon JA Jetten, Hugo JW Aerts, Ralf Herwig, Daniël HJ Theunissen, Stan Gaj, Joost H van Delft & Jos CS Kleinjans. (2014) Evaluation of database-derived pathway development for enabling biomarker discovery for hepatotoxicity. Biomarkers in Medicine 8:2, pages 185-200.
Crossref
Crossref
Minjun Chen, Halil Bisgin, Lillian Tong, Huixiao Hong, Hong Fang, Jürgen Borlak & Weida Tong. (2014) Toward predictive models for drug-induced liver injury in humans: are we there yet?. Biomarkers in Medicine 8:2, pages 201-213.
Crossref
Crossref
Yuping Wang, Jurgen Borlak & Weida Tong. 2014. Genomic Biomarkers for Pharmaceutical Development. Genomic Biomarkers for Pharmaceutical Development
127
155
.
Lisl K. M. Shoda, Jeffrey L. Woodhead, Scott Q. Siler, Paul B. Watkins & Brett A. Howell. (2014)
Linking physiology to toxicity using DILIsym
®
, a mechanistic mathematical model of drug-induced liver injury
. Biopharmaceutics & Drug Disposition 35:1, pages 33-49.
Crossref
Crossref
Travis T. Wager, Bethany L. Kormos, Joseph T. Brady, Yvonne Will, Michael D. Aleo, Donald B. Stedman, Max Kuhn & Ramalakshmi Y. Chandrasekaran. (2013) Improving the Odds of Success in Drug Discovery: Choosing the Best Compounds for in Vivo Toxicology Studies. Journal of Medicinal Chemistry 56:23, pages 9771-9779.
Crossref
Crossref
Minjun Chen, Huixiao Hong, Hong Fang, Reagan Kelly, Guangxu Zhou, Jürgen Borlak & Weida Tong. (2013) Quantitative Structure-Activity Relationship Models for Predicting Drug-Induced Liver Injury Based on FDA-Approved Drug Labeling Annotation and Using a Large Collection of Drugs. Toxicological Sciences 136:1, pages 242-249.
Crossref
Crossref
James H. Lewis. (2013) Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharmaceutical Medicine 27:3, pages 165-191.
Crossref
Crossref
Yuping Wang, Zhi Lin, Zhichao Liu, Stephen Harris, Reagan Kelly, Jie Zhang, Weigong Ge, Minjun Chen, Jürgen Borlak & Weida Tong. (2013) A Unifying Ontology to Integrate Histological and Clinical Observations for Drug-Induced Liver Injury. The American Journal of Pathology 182:4, pages 1180-1187.
Crossref
Crossref
William Bart Emary & Nanyan Rena Zhang. 2013. Mass Spectrometry for Drug Discovery and Drug Development. Mass Spectrometry for Drug Discovery and Drug Development
37
54
.
Andrew R. Leach, Kendall Wallace, Nathalie Alepee, George Daston, Colin Humphris, Irene Manou, Sandeep Modi, Stephanie Ringeissen, Maurice Whelan & Ian Kimber. (2012) Reprint of: Characterising hepatic mitochondrial function as a model for systemic toxicity: A commentary. Toxicology 302:2-3, pages e1-e4.
Crossref
Crossref
Patrick Y. Muller & Mark N. Milton. (2012) The determination and interpretation of the therapeutic index in drug development. Nature Reviews Drug Discovery 11:10, pages 751-761.
Crossref
Crossref